Actinobacteria from Antarctica as a source for anticancer discovery.

Abstract: Although many advances have been achieved to treat aggressive tumours, cancer remains a leading cause of death and a public health problem worldwide. Among the main approaches for the discovery of new bioactive agents, the prospect of microbial secondary metabolites represents an effective source for the development of drug leads. In this study, we investigated the actinobacterial diversity associated with an endemic Antarctic species, Deschampsia antarctica, by integrated culture-dependent and culture-independent methods and acknowledged this niche as a reservoir of bioactive strains for the production of antitumour compounds. The 16S rRNA-based analysis showed the predominance of the Actinomycetales order, a well-known group of bioactive metabolite producers belonging to the Actinobacteria phylum. Cultivation techniques were applied, and 72 psychrotolerant Actinobacteria strains belonging to the genera Actinoplanes, Arthrobacter, Kribbella, Mycobacterium, Nocardia, Pilimelia, Pseudarthrobacter, Rhodococcus, Streptacidiphilus, Streptomyces and Tsukamurella were identified. The secondary metabolites were screened, and 17 isolates were identified as promising antitumour compound producers. However, the bio-guided assay showed a pronounced antiproliferative activity for the crude extracts of Streptomyces sp. CMAA 1527 and Streptomyces sp. CMAA 1653. The TGI and LC50 values revealed the potential of these natural products to control the proliferation of breast (MCF-7), glioblastoma (U251), lung/non-small (NCI-H460) and kidney (786-0) human cancer cell lines. Cinerubin B and actinomycin V were the predominant compounds identified in Streptomyces sp. CMAA 1527 and Streptomyces sp. CMAA 1653, respectively. Our results suggest that the rhizosphere of D. antarctica represents a prominent reservoir of bioactive actinobacteria strains and reveals it as an important environment for potential antitumour agents.

Saved in:
Bibliographic Details
Main Authors: SILVA, L. J. da, CREVELIN, E. J., SOUZA, D. T., LACERDA JÚNIOR, G. V., OLIVEIRA, V. M., RUIZ, A. L. T. G., ROSA, L. H., MORAES, L. A. B., MELO, I. S. de
Other Authors: LEONARDO JOSÉ SILVA, ESALQ-USP; EDUARDO JOSÉ CREVELIN, FFCLRP-USP; DANILO TOSTA SOUZA, FFCLRP-USP; GILENO VIEIRA LACERDA JÚNIOR; VALERIA MAIA DE OLIVEIRA, CPQBA-UNICAMP; ANA LUCIA TASCA GOIS RUIZ, FCF-UNICAMP; LUIZ HENRIQUE ROSA, UFMG; LUIZ ALBERTO BERALDO MORAES, FFCLRP-USP; ITAMAR SOARES DE MELO, CNPMA.
Format: Artigo de periódico biblioteca
Language:Ingles
English
Published: 2020-12-29
Subjects:Anticancer activity, Antitumoral activity, Bactéria não Patogênica, Câncer, Actinobacteria, Antarctica,
Online Access:http://www.alice.cnptia.embrapa.br/alice/handle/doc/1128824
https://doi.org/10.1038/s41598-020-69786-2
Tags: Add Tag
No Tags, Be the first to tag this record!
id dig-alice-doc-1128824
record_format koha
spelling dig-alice-doc-11288242020-12-30T09:02:36Z Actinobacteria from Antarctica as a source for anticancer discovery. SILVA, L. J. da CREVELIN, E. J. SOUZA, D. T. LACERDA JÚNIOR, G. V. OLIVEIRA, V. M. RUIZ, A. L. T. G. ROSA, L. H. MORAES, L. A. B. MELO, I. S. de LEONARDO JOSÉ SILVA, ESALQ-USP; EDUARDO JOSÉ CREVELIN, FFCLRP-USP; DANILO TOSTA SOUZA, FFCLRP-USP; GILENO VIEIRA LACERDA JÚNIOR; VALERIA MAIA DE OLIVEIRA, CPQBA-UNICAMP; ANA LUCIA TASCA GOIS RUIZ, FCF-UNICAMP; LUIZ HENRIQUE ROSA, UFMG; LUIZ ALBERTO BERALDO MORAES, FFCLRP-USP; ITAMAR SOARES DE MELO, CNPMA. Anticancer activity Antitumoral activity Bactéria não Patogênica Câncer Actinobacteria Antarctica Abstract: Although many advances have been achieved to treat aggressive tumours, cancer remains a leading cause of death and a public health problem worldwide. Among the main approaches for the discovery of new bioactive agents, the prospect of microbial secondary metabolites represents an effective source for the development of drug leads. In this study, we investigated the actinobacterial diversity associated with an endemic Antarctic species, Deschampsia antarctica, by integrated culture-dependent and culture-independent methods and acknowledged this niche as a reservoir of bioactive strains for the production of antitumour compounds. The 16S rRNA-based analysis showed the predominance of the Actinomycetales order, a well-known group of bioactive metabolite producers belonging to the Actinobacteria phylum. Cultivation techniques were applied, and 72 psychrotolerant Actinobacteria strains belonging to the genera Actinoplanes, Arthrobacter, Kribbella, Mycobacterium, Nocardia, Pilimelia, Pseudarthrobacter, Rhodococcus, Streptacidiphilus, Streptomyces and Tsukamurella were identified. The secondary metabolites were screened, and 17 isolates were identified as promising antitumour compound producers. However, the bio-guided assay showed a pronounced antiproliferative activity for the crude extracts of Streptomyces sp. CMAA 1527 and Streptomyces sp. CMAA 1653. The TGI and LC50 values revealed the potential of these natural products to control the proliferation of breast (MCF-7), glioblastoma (U251), lung/non-small (NCI-H460) and kidney (786-0) human cancer cell lines. Cinerubin B and actinomycin V were the predominant compounds identified in Streptomyces sp. CMAA 1527 and Streptomyces sp. CMAA 1653, respectively. Our results suggest that the rhizosphere of D. antarctica represents a prominent reservoir of bioactive actinobacteria strains and reveals it as an important environment for potential antitumour agents. 2020-12-30T09:02:29Z 2020-12-30T09:02:29Z 2020-12-29 2020 Artigo de periódico Scientific Reports, v. 10, article 13870, 2020. 2045-2322 http://www.alice.cnptia.embrapa.br/alice/handle/doc/1128824 https://doi.org/10.1038/s41598-020-69786-2 Ingles en openAccess p. 1-15.
institution EMBRAPA
collection DSpace
country Brasil
countrycode BR
component Bibliográfico
access En linea
databasecode dig-alice
tag biblioteca
region America del Sur
libraryname Sistema de bibliotecas de EMBRAPA
language Ingles
English
topic Anticancer activity
Antitumoral activity
Bactéria não Patogênica
Câncer
Actinobacteria
Antarctica
Anticancer activity
Antitumoral activity
Bactéria não Patogênica
Câncer
Actinobacteria
Antarctica
spellingShingle Anticancer activity
Antitumoral activity
Bactéria não Patogênica
Câncer
Actinobacteria
Antarctica
Anticancer activity
Antitumoral activity
Bactéria não Patogênica
Câncer
Actinobacteria
Antarctica
SILVA, L. J. da
CREVELIN, E. J.
SOUZA, D. T.
LACERDA JÚNIOR, G. V.
OLIVEIRA, V. M.
RUIZ, A. L. T. G.
ROSA, L. H.
MORAES, L. A. B.
MELO, I. S. de
Actinobacteria from Antarctica as a source for anticancer discovery.
description Abstract: Although many advances have been achieved to treat aggressive tumours, cancer remains a leading cause of death and a public health problem worldwide. Among the main approaches for the discovery of new bioactive agents, the prospect of microbial secondary metabolites represents an effective source for the development of drug leads. In this study, we investigated the actinobacterial diversity associated with an endemic Antarctic species, Deschampsia antarctica, by integrated culture-dependent and culture-independent methods and acknowledged this niche as a reservoir of bioactive strains for the production of antitumour compounds. The 16S rRNA-based analysis showed the predominance of the Actinomycetales order, a well-known group of bioactive metabolite producers belonging to the Actinobacteria phylum. Cultivation techniques were applied, and 72 psychrotolerant Actinobacteria strains belonging to the genera Actinoplanes, Arthrobacter, Kribbella, Mycobacterium, Nocardia, Pilimelia, Pseudarthrobacter, Rhodococcus, Streptacidiphilus, Streptomyces and Tsukamurella were identified. The secondary metabolites were screened, and 17 isolates were identified as promising antitumour compound producers. However, the bio-guided assay showed a pronounced antiproliferative activity for the crude extracts of Streptomyces sp. CMAA 1527 and Streptomyces sp. CMAA 1653. The TGI and LC50 values revealed the potential of these natural products to control the proliferation of breast (MCF-7), glioblastoma (U251), lung/non-small (NCI-H460) and kidney (786-0) human cancer cell lines. Cinerubin B and actinomycin V were the predominant compounds identified in Streptomyces sp. CMAA 1527 and Streptomyces sp. CMAA 1653, respectively. Our results suggest that the rhizosphere of D. antarctica represents a prominent reservoir of bioactive actinobacteria strains and reveals it as an important environment for potential antitumour agents.
author2 LEONARDO JOSÉ SILVA, ESALQ-USP; EDUARDO JOSÉ CREVELIN, FFCLRP-USP; DANILO TOSTA SOUZA, FFCLRP-USP; GILENO VIEIRA LACERDA JÚNIOR; VALERIA MAIA DE OLIVEIRA, CPQBA-UNICAMP; ANA LUCIA TASCA GOIS RUIZ, FCF-UNICAMP; LUIZ HENRIQUE ROSA, UFMG; LUIZ ALBERTO BERALDO MORAES, FFCLRP-USP; ITAMAR SOARES DE MELO, CNPMA.
author_facet LEONARDO JOSÉ SILVA, ESALQ-USP; EDUARDO JOSÉ CREVELIN, FFCLRP-USP; DANILO TOSTA SOUZA, FFCLRP-USP; GILENO VIEIRA LACERDA JÚNIOR; VALERIA MAIA DE OLIVEIRA, CPQBA-UNICAMP; ANA LUCIA TASCA GOIS RUIZ, FCF-UNICAMP; LUIZ HENRIQUE ROSA, UFMG; LUIZ ALBERTO BERALDO MORAES, FFCLRP-USP; ITAMAR SOARES DE MELO, CNPMA.
SILVA, L. J. da
CREVELIN, E. J.
SOUZA, D. T.
LACERDA JÚNIOR, G. V.
OLIVEIRA, V. M.
RUIZ, A. L. T. G.
ROSA, L. H.
MORAES, L. A. B.
MELO, I. S. de
format Artigo de periódico
topic_facet Anticancer activity
Antitumoral activity
Bactéria não Patogênica
Câncer
Actinobacteria
Antarctica
author SILVA, L. J. da
CREVELIN, E. J.
SOUZA, D. T.
LACERDA JÚNIOR, G. V.
OLIVEIRA, V. M.
RUIZ, A. L. T. G.
ROSA, L. H.
MORAES, L. A. B.
MELO, I. S. de
author_sort SILVA, L. J. da
title Actinobacteria from Antarctica as a source for anticancer discovery.
title_short Actinobacteria from Antarctica as a source for anticancer discovery.
title_full Actinobacteria from Antarctica as a source for anticancer discovery.
title_fullStr Actinobacteria from Antarctica as a source for anticancer discovery.
title_full_unstemmed Actinobacteria from Antarctica as a source for anticancer discovery.
title_sort actinobacteria from antarctica as a source for anticancer discovery.
publishDate 2020-12-29
url http://www.alice.cnptia.embrapa.br/alice/handle/doc/1128824
https://doi.org/10.1038/s41598-020-69786-2
work_keys_str_mv AT silvaljda actinobacteriafromantarcticaasasourceforanticancerdiscovery
AT crevelinej actinobacteriafromantarcticaasasourceforanticancerdiscovery
AT souzadt actinobacteriafromantarcticaasasourceforanticancerdiscovery
AT lacerdajuniorgv actinobacteriafromantarcticaasasourceforanticancerdiscovery
AT oliveiravm actinobacteriafromantarcticaasasourceforanticancerdiscovery
AT ruizaltg actinobacteriafromantarcticaasasourceforanticancerdiscovery
AT rosalh actinobacteriafromantarcticaasasourceforanticancerdiscovery
AT moraeslab actinobacteriafromantarcticaasasourceforanticancerdiscovery
AT meloisde actinobacteriafromantarcticaasasourceforanticancerdiscovery
_version_ 1756027333796429824